{
  "nct_id": "NCT12345679",
  "indication": "Diabetes",
  "phase": "Phase 3",
  "sample_size": 500,
  "duration_weeks": 52,
  "dropout_rate": 0.12,
  "primary_endpoints": ["HbA1c reduction >=0.5%"],
  "control_arm": "active comparator",
  "blinding": "double-blind",
  "outcome_summary": "Primary endpoint met with statistical significance (p<0.01)",
  "failure_reason": "N/A"
}